European Strategic Botanical Infrastructure
Since 1992 – Structured Development Program
A long-term European agro-industrial initiative
focused on pharmaceutical-grade Ginkgo biloba leaf production.
4 Hectares · 40,000 Plants · Mechanical Harvest · First Industrial Cycle 2033
Strategic Background
The GINKGO PHARMA® program represents more than three decades of botanical development.
Conceptual foundation: 1992
Structured expansion: post-2009
Field consolidation: 2021
Laboratory transition: 2026
European plantation phase: 2029
The European layer transforms a long-term botanical program into permanent agricultural infrastructure within the European Union.
Industrial Objective
The project establishes a high-density perennial plantation system for standardized leaf biomass production.
Primary characteristics:
- 4 hectares in Northern Italy
- 10,000 plants per hectare
- 40,000 total plants
- mechanized harvesting
- annual structural regulation (~2 m)
- non-irrigated cultivation model
- bio-oriented agricultural framework
First industrial harvest projected: 2033.
European Strategic Relevance
The initiative contributes to:
- European botanical raw material autonomy
- Long-term agro-industrial infrastructure
- Climate-adapted perennial cultivation
- Sustainable regional diversification
- Pharmaceutical supply chain resilience
The plantation is structured as permanent agricultural infrastructure,
not a short-term crop operation.